Photonamic Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 25

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 5

Photonamic General Information

Description

Developer of five-aminolevulinic acid-based photosensitizers intended for fluorescence diagnosis and photodynamic therapy. The company's products are interoperative diagnostic drugs that are used in galenic formulations and application systems for a variety of indications, thereby assisting in the areas of oncology and dermatology as well as in cosmetics and food supplements.

Contact Information

Website
www.photonamic.de
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Eggerstedter Weg 12
  • 25421 Pinneberg
  • Germany
+49 04101
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Multi-line Chemicals
Corporate Office
  • Eggerstedter Weg 12
  • 25421 Pinneberg
  • Germany
+49 04101

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Photonamic Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Photonamic‘s full profile, request access.

Request a free trial

Photonamic Patents

  • 39

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Photonamic Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190240166-A1 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Inactive 31-Aug-2011
CA-2844288-C Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Active 31-Aug-2011
ES-2646737-T3 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Active 31-Aug-2011
CA-2844288-A1 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Active 31-Aug-2011
AU-2012301042-B2 Transdermal therapeutic system for 5-aminolevulinic acid hydrochloride Active 31-Aug-2011 A61K31/197
To view Photonamic’s complete patent history, request access »

Photonamic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Photonamic Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Photonamic‘s full profile, request access.

Request a free trial

Photonamic Investments (5)

Photonamic’s most recent deal was a Buyout/LBO with FerroSens. The deal was made on 16-Apr-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
FerroSens 16-Apr-2021 Buyout/LBO Diagnostic Equipment
Photonics Healthcare 09-Oct-2019 Buyout/LBO Monitoring Equipment
MolecuLight 14-Aug-2019 Buyout/LBO Diagnostic Equipment
Photonamic (Imaging Platform For Tumor Surgeries, Canada) 14-Aug-2019 Buyout/LBO Surgical Devices
NX Development 30-Apr-2018 Buyout/LBO Biotechnology
To view Photonamic’s complete investments history, request access »

Photonamic Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
FerroSens Munich, Germany 2016
MolecuLight Toronto, Canada 2012
NX Development Lexington, KY 2010
Photonics Healthcare Utrecht, Netherlands 2009

Photonamic FAQs

  • When was Photonamic founded?

    Photonamic was founded in 2002.

  • Where is Photonamic headquartered?

    Photonamic is headquartered in Pinneberg, Germany.

  • What is the size of Photonamic?

    Photonamic has 25 total employees.

  • What industry is Photonamic in?

    Photonamic’s primary industry is Discovery Tools (Healthcare).

  • Is Photonamic a private or public company?

    Photonamic is a Private company.

  • What is Photonamic’s current revenue?

    The current revenue for Photonamic is .

  • Who are Photonamic’s investors?

    Medac Pharma and SBI Holdings have invested in Photonamic.

  • When was Photonamic acquired?

    Photonamic was acquired on 01-Sep-2023.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »